Cargando…

Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression

BACKGROUND: Some studies have reported that preeclampsia with COVID-19 significantly increases the risk of adverse perinatal outcomes to nearly 3-fold in normal pregnancy. In theory, the pathophysiology of preeclampsia increases perinatal mortality and morbidity starting from placental injury, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Bachnas, Muhammad Adrianes, Putri, Aira Oklatihana, Rahmi, Elita, Pranabakti, Rosita Alifa, Anggraini, Nutria Widya Purna, Astetri, Lini, Yuliantara, Eric Edwin, Prabowo, Wisnu, Respati, Supriyadi Hari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257336/
https://www.ncbi.nlm.nih.gov/pubmed/37362630
http://dx.doi.org/10.1016/j.xagr.2023.100234
_version_ 1785057281452277760
author Bachnas, Muhammad Adrianes
Putri, Aira Oklatihana
Rahmi, Elita
Pranabakti, Rosita Alifa
Anggraini, Nutria Widya Purna
Astetri, Lini
Yuliantara, Eric Edwin
Prabowo, Wisnu
Respati, Supriyadi Hari
author_facet Bachnas, Muhammad Adrianes
Putri, Aira Oklatihana
Rahmi, Elita
Pranabakti, Rosita Alifa
Anggraini, Nutria Widya Purna
Astetri, Lini
Yuliantara, Eric Edwin
Prabowo, Wisnu
Respati, Supriyadi Hari
author_sort Bachnas, Muhammad Adrianes
collection PubMed
description BACKGROUND: Some studies have reported that preeclampsia with COVID-19 significantly increases the risk of adverse perinatal outcomes to nearly 3-fold in normal pregnancy. In theory, the pathophysiology of preeclampsia increases perinatal mortality and morbidity starting from placental injury, which is also believed to share a common pathway with COVID-19. Moreover, major placental injuries could be apoptotic, necrotic, or pyroptotic. OBJECTIVE: This study aimed to compare the placental damage between Preeclampsia with COVID-19, COVID-19, and preeclampsia in apoptotic, necrotic, or pyroptotic injuries. STUDY DESIGN: This was an observational analytical study with a cross-sectional setting. A total of 72 pregnant women were admitted to the hospital with diagnoses of preeclampsia with COVID-19, preeclampsia, and COVID-19. The diagnosis for preeclampsia was following the International Federation of Gynecology and Obstetrics criteria with at least 1 of the severe features. Patients with COVID-19 were eligible if they had a confirmatory polymerase chain reaction test with moderate to severe clinical degree. The placentas were taken after delivery, and the parameters were quantified with immunohistochemistry tests for caspase-3, caspase-1, and tumor necrosis factor-alpha representing apoptotic, pyroptotic, and necrotic pathways, respectively. RESULTS: Pregnancies complicated by both COVID-19 and preeclampsia, preeclampsia, and COVID-19 significantly had the highest placental damage on apoptotic, pyroptotic, and necrotic pathways shown from caspase-3, caspase-1, and tumor necrosis factor-alpha expressions in the placenta (P<.05). Moderate to severe degree of COVID-19 resulted in higher placental damage than preeclampsia in all 3 forms (P<.05). The apoptotic process was the most prominent among the pathways. CONCLUSION: Preeclampsia with COVID-19 showed significant placental damage, with major changes related to apoptosis, inflammation, and necrosis. Our data support poor perinatal outcomes of pregnancies complicated by both preeclampsia and COVID-19.
format Online
Article
Text
id pubmed-10257336
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-102573362023-06-12 Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression Bachnas, Muhammad Adrianes Putri, Aira Oklatihana Rahmi, Elita Pranabakti, Rosita Alifa Anggraini, Nutria Widya Purna Astetri, Lini Yuliantara, Eric Edwin Prabowo, Wisnu Respati, Supriyadi Hari AJOG Glob Rep Original Research BACKGROUND: Some studies have reported that preeclampsia with COVID-19 significantly increases the risk of adverse perinatal outcomes to nearly 3-fold in normal pregnancy. In theory, the pathophysiology of preeclampsia increases perinatal mortality and morbidity starting from placental injury, which is also believed to share a common pathway with COVID-19. Moreover, major placental injuries could be apoptotic, necrotic, or pyroptotic. OBJECTIVE: This study aimed to compare the placental damage between Preeclampsia with COVID-19, COVID-19, and preeclampsia in apoptotic, necrotic, or pyroptotic injuries. STUDY DESIGN: This was an observational analytical study with a cross-sectional setting. A total of 72 pregnant women were admitted to the hospital with diagnoses of preeclampsia with COVID-19, preeclampsia, and COVID-19. The diagnosis for preeclampsia was following the International Federation of Gynecology and Obstetrics criteria with at least 1 of the severe features. Patients with COVID-19 were eligible if they had a confirmatory polymerase chain reaction test with moderate to severe clinical degree. The placentas were taken after delivery, and the parameters were quantified with immunohistochemistry tests for caspase-3, caspase-1, and tumor necrosis factor-alpha representing apoptotic, pyroptotic, and necrotic pathways, respectively. RESULTS: Pregnancies complicated by both COVID-19 and preeclampsia, preeclampsia, and COVID-19 significantly had the highest placental damage on apoptotic, pyroptotic, and necrotic pathways shown from caspase-3, caspase-1, and tumor necrosis factor-alpha expressions in the placenta (P<.05). Moderate to severe degree of COVID-19 resulted in higher placental damage than preeclampsia in all 3 forms (P<.05). The apoptotic process was the most prominent among the pathways. CONCLUSION: Preeclampsia with COVID-19 showed significant placental damage, with major changes related to apoptosis, inflammation, and necrosis. Our data support poor perinatal outcomes of pregnancies complicated by both preeclampsia and COVID-19. Elsevier 2023-06-10 /pmc/articles/PMC10257336/ /pubmed/37362630 http://dx.doi.org/10.1016/j.xagr.2023.100234 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Original Research
Bachnas, Muhammad Adrianes
Putri, Aira Oklatihana
Rahmi, Elita
Pranabakti, Rosita Alifa
Anggraini, Nutria Widya Purna
Astetri, Lini
Yuliantara, Eric Edwin
Prabowo, Wisnu
Respati, Supriyadi Hari
Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
title Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
title_full Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
title_fullStr Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
title_full_unstemmed Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
title_short Placental damage comparison between preeclampsia with COVID-19, COVID-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
title_sort placental damage comparison between preeclampsia with covid-19, covid-19, and preeclampsia: analysis of caspase-3, caspase-1, and tumor necrosis factor-alpha expression
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257336/
https://www.ncbi.nlm.nih.gov/pubmed/37362630
http://dx.doi.org/10.1016/j.xagr.2023.100234
work_keys_str_mv AT bachnasmuhammadadrianes placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT putriairaoklatihana placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT rahmielita placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT pranabaktirositaalifa placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT anggraininutriawidyapurna placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT astetrilini placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT yuliantaraericedwin placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT prabowowisnu placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression
AT respatisupriyadihari placentaldamagecomparisonbetweenpreeclampsiawithcovid19covid19andpreeclampsiaanalysisofcaspase3caspase1andtumornecrosisfactoralphaexpression